GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026)
GE HealthCare Technologies posted quarterly Income from Non-Controlling Interests of $22.0 million for Q1 2026, down 8.33% year-on-year from $24.0 million in Q1 2025, and up 69.23% on a QoQ basis from $13.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) has 5 years of Income from Non-Controlling Interests data on file, last reported at $22.0 million in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 8.33% year-over-year to $22.0 million; the trailing twelve-month figure through Mar 2026 stood at $67.0 million (changed 0.0% YoY), and the FY2025 full-year result was $70.0 million, up 22.81% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $22.0 million, up from $13.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $24.0 million in Q1 2025 and bottomed at $6.0 million in Q3 2022.
- The 5-year median for Income from Non-Controlling Interests is $14.0 million (2024), against an average of $14.4 million.
- Peak annual rise in Income from Non-Controlling Interests reached 171.43% in 2024, while the deepest fall reached 53.33% in 2024.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $19.0 million in 2022, then sank by 31.58% to $13.0 million in 2023, then jumped by 30.77% to $17.0 million in 2024, then slipped by 23.53% to $13.0 million in 2025, then surged by 69.23% to $22.0 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $22.0 million (Q1 2026), $13.0 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 24.00 Mn |
| Dec 31, 2024 | 17.00 Mn |
| Sep 30, 2024 | 19.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 13.00 Mn |
| Mar 31, 2022 | 13.00 Mn |